212 related articles for article (PubMed ID: 17457218)
1. Inability to mediate prolonged reduction of regulatory T Cells after transfer of autologous CD25-depleted PBMC and interleukin-2 after lymphodepleting chemotherapy.
Powell DJ; de Vries CR; Allen T; Ahmadzadeh M; Rosenberg SA
J Immunother; 2007; 30(4):438-47. PubMed ID: 17457218
[TBL] [Abstract][Full Text] [Related]
2. Administration of a CD25-directed immunotoxin, LMB-2, to patients with metastatic melanoma induces a selective partial reduction in regulatory T cells in vivo.
Powell DJ; Felipe-Silva A; Merino MJ; Ahmadzadeh M; Allen T; Levy C; White DE; Mavroukakis S; Kreitman RJ; Rosenberg SA; Pastan I
J Immunol; 2007 Oct; 179(7):4919-28. PubMed ID: 17878392
[TBL] [Abstract][Full Text] [Related]
3. Partial reduction of human FOXP3+ CD4 T cells in vivo after CD25-directed recombinant immunotoxin administration.
Powell DJ; Attia P; Ghetie V; Schindler J; Vitetta ES; Rosenberg SA
J Immunother; 2008; 31(2):189-98. PubMed ID: 18481388
[TBL] [Abstract][Full Text] [Related]
4. Large-scale depletion of CD25+ regulatory T cells from patient leukapheresis samples.
Powell DJ; Parker LL; Rosenberg SA
J Immunother; 2005; 28(4):403-11. PubMed ID: 16000960
[TBL] [Abstract][Full Text] [Related]
5. Increase of circulating CD4+CD25highFoxp3+ regulatory T cells in patients with metastatic renal cell carcinoma during treatment with dendritic cell vaccination and low-dose interleukin-2.
Berntsen A; Brimnes MK; thor Straten P; Svane IM
J Immunother; 2010 May; 33(4):425-34. PubMed ID: 20386464
[TBL] [Abstract][Full Text] [Related]
6. Differential responses of human regulatory T cells (Treg) and effector T cells to rapamycin.
Strauss L; Czystowska M; Szajnik M; Mandapathil M; Whiteside TL
PLoS One; 2009 Jun; 4(6):e5994. PubMed ID: 19543393
[TBL] [Abstract][Full Text] [Related]
7. A unique subset of CD4+CD25highFoxp3+ T cells secreting interleukin-10 and transforming growth factor-beta1 mediates suppression in the tumor microenvironment.
Strauss L; Bergmann C; Szczepanski M; Gooding W; Johnson JT; Whiteside TL
Clin Cancer Res; 2007 Aug; 13(15 Pt 1):4345-54. PubMed ID: 17671115
[TBL] [Abstract][Full Text] [Related]
8. Absence of amplification of CD4+CD25(high) regulatory T cells during in vitro expansion of tumor-infiltrating lymphocytes in melanoma patients.
Knol AC; Lemaître F; Pandolfino MC; Volteau C; Quéreux G; Saiagh S; Khammari A; Viguier M; Dréno B
Exp Dermatol; 2008 May; 17(5):436-45. PubMed ID: 18312383
[TBL] [Abstract][Full Text] [Related]
9. Preparation of functionally preserved CD4+ CD25high regulatory T cells from leukapheresis products from ulcerative colitis patients, applicable to regulatory T-cell transfer therapy.
Sumida Y; Nakamura K; Kanayama K; Akiho H; Teshima T; Takayanagi R
Cytotherapy; 2008; 10(7):698-710. PubMed ID: 18985477
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of regulatory T lymphocytes and IL2Ra and FOXP3 gene expression in peripheral mononuclear cells from patients with amyotrophic lateral sclerosis.
Rashid Chehreh Bargh S; Tafakhori A; Masoumi F; Rahmani F; Ahmadi M; Namdar A; Azimi M; Tavasolian P; Habibi S; Zamani B; Maserrat M; Sadr M; Noorbakhsh F; Rezaei N
Ir J Med Sci; 2018 Nov; 187(4):1065-1071. PubMed ID: 29574662
[TBL] [Abstract][Full Text] [Related]
11. IL-2 contributes to maintaining a balance between CD4+Foxp3+ regulatory T cells and effector CD4+ T cells required for immune control of blood-stage malaria infection.
Berretta F; St-Pierre J; Piccirillo CA; Stevenson MM
J Immunol; 2011 Apr; 186(8):4862-71. PubMed ID: 21389253
[TBL] [Abstract][Full Text] [Related]
12. In vitro induction of functional allergen-specific CD4+ CD25high Treg cells in horses affected with insect bite hypersensitivity.
Hamza E; Akdis CA; Wagner B; Steinbach F; Marti E
Clin Exp Allergy; 2013 Aug; 43(8):889-901. PubMed ID: 23889243
[TBL] [Abstract][Full Text] [Related]
13. Dendritic cell vaccination in combination with anti-CD25 monoclonal antibody treatment: a phase I/II study in metastatic melanoma patients.
Jacobs JF; Punt CJ; Lesterhuis WJ; Sutmuller RP; Brouwer HM; Scharenborg NM; Klasen IS; Hilbrands LB; Figdor CG; de Vries IJ; Adema GJ
Clin Cancer Res; 2010 Oct; 16(20):5067-78. PubMed ID: 20736326
[TBL] [Abstract][Full Text] [Related]
14. Depletion of CD4+CD25+ human regulatory T cells in vivo: kinetics of Treg depletion and alterations in immune functions in vivo and in vitro.
Mahnke K; Schönfeld K; Fondel S; Ring S; Karakhanova S; Wiedemeyer K; Bedke T; Johnson TS; Storn V; Schallenberg S; Enk AH
Int J Cancer; 2007 Jun; 120(12):2723-33. PubMed ID: 17315189
[TBL] [Abstract][Full Text] [Related]
15. Forced overexpression of either of the two common human Foxp3 isoforms can induce regulatory T cells from CD4(+)CD25(-) cells.
Aarts-Riemens T; Emmelot ME; Verdonck LF; Mutis T
Eur J Immunol; 2008 May; 38(5):1381-90. PubMed ID: 18412171
[TBL] [Abstract][Full Text] [Related]
16. Providence of the CD25
Chakraborty S; Bhattacharjee P; Panda AK; Kajal K; Bose S; Sa G
Immunol Cell Biol; 2018 Nov; 96(10):1035-1048. PubMed ID: 29768737
[TBL] [Abstract][Full Text] [Related]
17. Downregulation of CD4+CD25+ regulatory T cells may underlie enhanced Th1 immunity caused by immunization with activated autologous T cells.
Cao Q; Wang L; Du F; Sheng H; Zhang Y; Wu J; Shen B; Shen T; Zhang J; Li D; Li N
Cell Res; 2007 Jul; 17(7):627-37. PubMed ID: 17563757
[TBL] [Abstract][Full Text] [Related]
18. Short-term cytokine stimulation reveals regulatory T cells with down-regulated Foxp3 expression in human peripheral blood.
Tabares P; Berr S; Langenhorst D; Sawitzki B; Ten Berge I; Tony HP; Hünig T
Eur J Immunol; 2018 Feb; 48(2):366-379. PubMed ID: 29023682
[TBL] [Abstract][Full Text] [Related]
19. Interleukin-7 optimizes FOXP3+CD4+ regulatory T cells reactivity to interleukin-2 by modulating CD25 expression.
Simonetta F; Gestermann N; Bloquet S; Bourgeois C
PLoS One; 2014; 9(12):e113314. PubMed ID: 25485946
[TBL] [Abstract][Full Text] [Related]
20. Regulatory T (Treg) cells in cancer: Can Treg cells be a new therapeutic target?
Ohue Y; Nishikawa H
Cancer Sci; 2019 Jul; 110(7):2080-2089. PubMed ID: 31102428
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]